Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
5
×
national blog main
national top stories
texas blog main
texas top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
wisconsin blog main
wisconsin top stories
medical devices
accent therapeutics
aducanumab
alexion pharmaceuticals
alzheimer's disease
asklepios biopharmaceutical
biogen
bridgebio
bristol-myers squibb
cancer immunotherapy
What
new
5
×
roundup
5
×
bio
drug
news
activity
advantages
announced
approval
approvals
bails
bar
biobridge
biogen
biogen’s
biopharmaceutical
brand
bridgebio
brings
capital
car
catch
center
clamped
companies
convo
covid
delays
develop
developing
drugs
earlier
economic
emerges
execs
expansion
expect
failures
fannin
fast
Language
unset
Current search:
roundup
×
new
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
TX Roundup: TMC’s BioBridge to the UK, New Execs at Fannin & TechFW